Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex has appointed a new commercial head for ex-US activites, as the company aims to resolve its two-year row with UK health officials over the price of its cystic fibrosis drugs.

The 247Sports Transfer Portal includes players who have either announced their intent to enter or have officially entered the NCAA Transfer Portal. Under the college transfer policy, when a ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

There are not any players in the transfer portal for this selection.

There are not any players in the transfer portal for this selection.